Ranbaxy Eyes Partners for Malaria Drug R&D

A year after Geneva-based Medicines for Malaria Venture (MMV) walked out of its joint malarial drug research programme with India’s leading drug maker Ranbaxy Laboratories, the latter has decided to rope in fresh international collaborators for the project. 
Business Standard